Text Module

Share

Program Content

Activities

  • Targeting AKT in HER2-Negative BC
    Targeting AKT in HER2-Negative Breast Cancer: Implications for Future Clinical Practice
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 27, 2023

    Expires: July 26, 2024

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca